Work

A Pilot Study of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed and Refractory Classical Hodgkin Lymphoma (HL): Delivering Cross Fire Radiation by Targeting Reactive B Cells in the Microenvironment.

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.4791.4791

Authors: Anas Younes, Jorge E. Romaguera, Peter McLaughlin, Franklin Wong

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559966749

FWCI: 0.254

Cites:

Cited by: 2

Related to: 10